The Merlin team had a very successful plenary in Rotterdam on 10 and 11 May. Updates were presented on each WP. MSC production and preparation for the upcoming trial were naturally a key focus at this stage of the project. Publications and plans for future work were also discussed. Many thanks to EMC for hosting and to all the partners for their input into a very productive and enjoyable meeting!
- Support for the FDA’s tougher stance on unproven cell therapies: an interview with Prof Massimo Dominici t.co/QrLkbysLoa Time ago 1 Day via Hootsuite
- Health-EU Newsletter 200th edition Your gateway to trustworthy information on public health t.co/XRSQIqWNQH Time ago 2 Days via Hootsuite
- Register for the Health-EU newsletter: a source of public health information. t.co/gEy3lpiA5N t.co/829CBxCS4e Time ago 2 Days via Hootsuite
Follow @fp7merlin on twitter.
This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 602363. The material presented and views expressed here are the responsibility of the author(s) only. The EU Commission takes no responsibility for any use made of the information set out.